26.55500 EUR
0.47
1.80%
Last update Dec 17, 7:37 PM CET
Main market
Day range
26.11500
26.66500
Previous close
26.084999
Open
26.32000
Access this stock data via API
Subscribe
TG Therapeutics, Inc.
26.56
0.47
1.80%

Statistics

Valuation metrics
Market cap
0
Enterprise value
62.94M
Trailing P/E (ttm)
165.69
Forward P/E
PEG ratio
Price/Sales (ttm)
0
Price/Book (mrq)
Enterprise Value/Revenue
0.22
Enterprise Value/EBITDA
1.48
Overview
Shares outstanding
155.21M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
2
Average volume (90 days)
5
Price summary
52-Week low
22.29
52-Week high
40.32
52-Week change
-12.07 -54.2%
Beta
50-Day moving average
28.21
200-Day moving average
30.38
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
88.30%
Operating margin
15.08%
Operational effectiveness
Return on assets
4.05%
Return on equity
10.52%
Income statement
Revenue (ttm)
280.47M
Revenue per share (ttm)
2.26
Quarterly revenue growth (yoy)
14.57%
Gross profit (ttm)
247.66M
EBITDA
98.24M
Net income to common (ttm)
19.93M
Diluted EPS (ttm)
0.15
Quarterly earnings growth (yoy)
90.11%
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
216.29M
Total Debt/Equity (mrq)
0.42
Current ratio (mrq)
382.48%
Book value per share (mrq)
Cash flow
Cash flow statement
-52.63M
Levered free cash flow (LFCF)
330.83M
Access /statistics data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 10 hours 37 minutes

09:22
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).